QUOTED. May 24, 2018. John Mandrola.
Executive Summary
Single-center data presented at the Heart Rhythm Society annual meeting in Boston raised questions about failure rates for Abbott Laboratories's Tendril pacemaker leads. See what Baptist Health electrophysiologist John Mandrola said about it here.
This was a retrospective single-center study with nonrandomized group comparisons. It has serious limitations and is not yet published. That said, it's hard to dismiss an 18-fold greater risk for lead failure as spurious." – John Mandrola, electrophysiologist, Bapist Health (Louisville, Ky, US)
- Find out more: HRS 2018 Wrap-Up: Tendril Lead Failures; Metaanalysis Of Contact-Force Catheter; LuxCath's OmniView; More Micra Results
Click here for a free trial of Medtech Insight